Retinopathy of prematurity in infants of birth weight >2000 g after haemorrhagic shock at birth

British Journal of Ophthalmology

Volumn 80, Issue 8, 1996, Pages 728-731

  Jandeck, Claudia ^a   Kellner, Ulrich ^a   Kössel, Hans ^a   Bartsch, Marius ^a   Versmold, Hans T ^a   Foerster, Michael H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CRYOCOAGULATION; GENERAL ANESTHESIA; GESTATIONAL AGE; HEMATOCRIT; HEMORRHAGIC SHOCK; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; OXYGEN THERAPY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SOLUTIO PLACENTAE; UMBILICAL CORD BLOOD;

ABRUPTIO PLACENTAE; ANESTHESIA, GENERAL; BIRTH WEIGHT; BLOOD TRANSFUSION; BLOOD VOLUME; FEMALE; HEMATOCRIT; HUMANS; INFANT, NEWBORN; PREGNANCY; RETINOPATHY OF PREMATURITY; SHOCK, HEMORRHAGIC; SURGICAL PROCEDURES, OPERATIVE;

EID: 0029787207     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.8.728     Document Type: Article

References (47)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-9.
2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy. Arch Ophthalmol 1994;112:903-12.
3. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye 1992;6:233-42.
4. Flynn JT. Retinopathy of prematurity. Pediat Clin N Am 1987;34:1487-517.
5. Holmström G, el Azazi M, Jacobson L, Lennerstrand G. A population based, prospective study of the development of ROP in prematurely born children in the area of Sweden. Br J Ophthalmol 1993;77:417-23.
6. Jandeck C, Kellner U, Helbig H, Versmold H, Foerster MH. Natural course of retinal development in preterm infants below threshold retinopathy. Ger J Ophthalmol 1995;4: 131-6.
7. Ng YK, Fielder AR, Shaw DE, Levene MI. Epidemiology of retinopathy of prematurity. Lancet 1988;ii:1235-8.
8. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-40.
9. Quinn GE, Johnson L, Abbasi S. Onset of retinopathy of prematurity as related to postnatal and postconceptional age. Br J Ophthalmol 1992;76:284-8.
10. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, et al. Prognostic factors in the natural course of retinopathy of prematurity. Ophthalmology 1993;100: 230-7.
11. Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C, Jackson KL. Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol 1986;102:1-6.
12. Koerner F, Bossi E. Die Retinopathie des Frühgeborenen. Stuttgart: Fischer, 1984.
13. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity; 31/2-year outcome, structure and function. Arch Ophthalmol 1993;111:339-44.
14. Goggin M, O'Keefe M. Diode laser for retinopathy of prematurity-early outcome. Br J Ophthalmol 1993;77: 559-62.
15. Landers MB, Toth CA, Semple HC, Morse LS. Treatment of retinopathy of prematurity with argon laser photocoagulation. Arch Ophthalmol 1992;110:44-7.
16. McNamara JA, Tasman W, Brown GC, Federman JA. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology 1991;98:576-80.
17. Hindle NW. Cryotherapy for retinopathy of prematurity: timing of intervention. Br J Ophthalmol 1986;70:269-76,
18. Seiberth V, Knorz MC, Liesenhoff H. Acute retinopathy of prematurity: chances of a favorable outcome decrease when first treatment is performed after term. Invest Ophthalmol Vis Sci 1994;35:1653.
19. Petersen RA, Hunter DG, Mukai S. Retinopathy of prematurity. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology: clinical practice. Vol 4. Philadelphia: Saunders, 1994:2799-812.
20. Kellner U, Jandeck C, Helbig H, Versmold H, Bossi E, Körner F, et al. Überprüfung publizierter Empfehlungen für Screening-Untersuchungen bei Retinopathia prā-maturorum. Ophthalmologe 1995;92:681-4.
21. Fielder AR, Levene MI. Screening for retinopathy of prematurity. Arch Dis Child 1992;67:860-7.
22. Royal College of Ophthalmologists and British Association of Perinatal Medicine. Retinopathy of prematurity: guidelines for screening and treatment. The report of a joint working party, 1995.
23. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-4.
24. The International Committee for the Classification of the late Stages of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. Arch Ophthalmol 1987;105: 906-12.
25. Glader BE, Naimann JL. Erythrocyte disorders in infancy. In: Taeusch HW, Ballard RA, Avery HE, eds. Schaffer and Avery's diseases of the newborn. 6th ed. Philadelphia: Saunders, 1991:798-823.
26. Sharin SB. The blood and hematopoetic system. Neonatal-perinatal medicine. Diseases of the fetus and infant. 5th ed. St Louis: Mosby, 1992:941-1.
27. Palmer E, Patz A, Phelps DL, Spencer R. Retinopathy of prematurity. In: Ryan SJ, ed. Retina. 2nd ed. Vol 2. St Louis: Mosby, 1994:1473-98.
28. Cooke RWI, Clark D, Hickey-Dweyer M, Weindling AM. The apparent role of blood transfusions of retinopathy of prematurity. Eur J Pediatr 1993;152:833-6.
29. Sullivan J. ROP low iron binding capacity may contribute. [Letter] BMJ 1993;307:1353-4.
30. Saito Y, Omoto T, Cho Y, Hatsukawa Y, Fujimura M, Takeuchi T. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol 1993;231:151-6.
31. Penn JS, Tolman, BL, Lowery LA. Variable oxygen exposure causes prererinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci 1993;34:576-85.
32. Brockhurst RJ, Chishti M. Cicatricial retrolental fibroplasia: its occurrence without oxygen administration and in full term infants. Graefes Arch Klin Exp Ophthalmol 1975;195:113-28.
33. Kraushar MF, Harper RG, Sia CG. Retrolental fibroplasia in a full-term infant. Am J Ophthalmol 1975;80:106-8.
34. Schulman J, Jampol LM, Schwartz H. Peripheral proliferative retinopathy without oxygen therapy in a full-term infant. Am J Ophthalmol 1980;90:509-14.
35. Kushner BJ, Gloeckner E. Retrolental fibroplasia in full-term infants without exposure to supplemental oxygen. Am J Ophthalmol 1984;97:148-53.
36. Stefani FH, Ehalt H. Non-oxygen induced retinitis proliferans and retinal detachment in full-term infants. Br J Ophthalmol 1974;58:490-513,
37. Hittner HM. Retinal and central nervous system abnormalities: syndromes which resemble retrolental fibroplasia. Metab Pediatr Syst Ophthalmol 1985;8:5-10.
38. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol 1969;68:578-94.
39. Li Y, Müller B, Fuhrmann C, van Nouhuys CE, Laqua H, Humphries P, et al. The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to DIIS533. Am J Hum Genet 1992;51:749-54.
40. Plager DA, Orgel IK, Ellis FD, Hartzer M, Trese MT, Shastry BS. X-linked recessive familial exudative vitreoretinopathy. Am J Ophthalmol 1992;114:145-8.
41. Warburg M. Norrie's disease: a congenital progressive ocular-acoustico-cerebral degeneration. Acta Ophthalmol 1966;89:1-147.
42. Chen Z-Y, Battinelli EM, Woodruff G, Young I, Breakefield XO, Craig IW. Characterization of a mutation within the NDP gene in a family with a manifesting carrier. Hum Mol Genet 1993;2:1727-9.
43. Kellner U, Fuchs S, Bornfeld N, Foerster MH, Gal A. Ocular phenotypes associated with two mutations (R121W, C126X) in the Norrie disease gene. Ophthal Genet 1996; (in press).
44. Berger W, Meindl A, van de Pol TJR, Cremers FPM, Ropers HH, Doerner C, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nature Genet 1992;1: 199-203.
45. Chen Z-Y, Battinelli EM, Fielder A, Bundey S, Sims K, Breakefield XO, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nature Genet 1993;5:180-3.
46. Ravia Y, Braier-Goldstein O, Bat-Miriam KM, Erlich S, Barkai G, Goldman B. X-linked recessive primary retinal dysplasia is linked to the Norrie disease locus. Hum Mol Genet 1993;2:1295-7.
47. Fuchs S, Kellner U, Wedemann H, Gal A. Missense mutation (Arg121Trp) in the Norrie disease gene associated with X-linked exudative vitreoretinopathy. Hum Mutat 1995;6:257-9.